Rufinamide 200 mg Tablets Recalled for Manufacturing Process Deviation
Aurobindo Pharma USA Inc. is recalling Rufinamide 200 mg tablets (Lot RB2023001A) because a batch was released prior to manufacturing approval. The FDA classified this as a Class II recall.
- Product
- RUFINAMIDE — RUFINAMIDE (RUFINAMIDE)
- Category
- Drug
- Distribution
- Distributed nationwide